This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
While academic medical center radiology departments are expanding significantly and hospitals are adapting to health system consolidation trends, demand for innovative imaging informatics remains strong among operations and physician teams. Another, a new hospital complex is underway at University of Utah Health.
X-ray and ultrasound machines were badly damaged in a rocket attack on Ukraine's largest children's hospital on July 8, according to radiologist Stanislav Rebenkov, MD. Rebenkov has been head of radiology at Ohmatdyt Children's Hospital since 2020. Broken glass and damaged equipment are found throughout the hospital.
Middlebrooks, MD, Mayo Clinic, Jacksonville, FL Erik H. Middlebrooks, MD, of the Mayo Clinic in Jacksonville, FL. Given the extensive array of sequences and techniques employed in clinical imaging, we must address the inherent challenges associated with each," he noted. Middlebrooks, MD. Louis, MO Dmitry Beyder.
Most Influential Radiology Researcher Erik Middlebrooks, MD, Mayo Clinic, Jacksonville, FL Erik Middlebrooks, MD. One of this year's nominations for Most Influential Radiology Researcher is Erik Middlebrooks, MD, of the Mayo Clinic in Jacksonville, FL. He earned his medical degree from Washington University in St.
PET/CT imaging using gallium-68 (Ga-68) Fibroblast activation protein inhibitor (FAPI) radiotracer over F-18 FDG appears promising in women with invasive lobular carcinoma (ILC), according to a study published March 14 in the Journal of NuclearMedicine. Image courtesy of the Journal of NuclearMedicine.
Eliot Siegel, MD; Stanislav Spiridonov, MD; Nathan Gee, MD; and Anthony Chang, PhD, are among a niche gathering of early adopters, entrepreneurial physicians, medical physicists, and investors with a sweet spot for nuclearmedicine, diagnostic radiology, and radiation oncology.
As nuclearmedicine therapies gain stature compared to nuclearmedicine in diagnostic imaging, hospital administrators may be eyeing the potential of adding theranostics services. A shortage of nuclearmedicine technologists means a theranostics center may need to limit its patient volume.
FAPI-PET imaging could emerge as a new tool for assessing patients with single pulmonary tumors, especially in those with negative results on other scans, according to a study published April 11 in the Journal of NuclearMedicine. Image courtesy of the Journal of NuclearMedicine. “In
Fibroblast activation protein inhibitor (FAPI)-PET/CT appears superior to standard FDG-PET/CT for detecting gastrointestinal cancer, with higher radiotracer uptake seen in most tumors, according to a study published October 26 in the Journal of NuclearMedicine. Image courtesy of the Journal of NuclearMedicine.
The finding suggests that PET imaging of translocator protein (TSPO) in the brain can serve as a biomarker for evaluating patients whose disease progresses despite treatment, noted lead author Tarun Singhal, MD, of Brigham and Women’s Hospital and colleagues. Image courtesy of ClinicalNuclearMedicine.
Massachusetts General Hospital (MGH) radiologist Umar Mahmood, MD, PhD, has been named president of the board of directors of the Radiological Society of North America (RSNA), the group announced at its 2024 annual meeting in Chicago. Umar Mahmood, MD, PhD. Umar Mahmood, MD, PhD.
They're also mindful of the multiple dedicated teams required to build a theranostics clinic properly. Hope, vice chair of clinical operations and strategy in the UCSF department of radiology, established the radioligand therapy group at the university. Theranostics is becoming a treatment option for a larger volume of cancer patients.
milla1cf Tue, 06/11/2024 - 18:49 June 11, 2024 — The Society of NuclearMedicine and Molecular Imaging recognized six new SNMMI Fellows during a plenary session at the society’s 2024 Annual Meeting, held June 8-11 in Toronto. Also recognized were: Donna Cross , PhD, University of Utah , Salt Lake City, Utah Frederick D.
FAPI-PET imaging may become a powerful diagnostic tool for detecting pancreatic cancer, according to a study published November 16 in the Journal of NuclearMedicine. Image courtesy of the Journal of NuclearMedicine. In this study, the researchers analyzed data on 62 patients with suspected pancreatic cancer.
“This is a potentially practice-changing trial,” said Oliver Sartor, MD, a medical oncologist and director of radiopharmaceutical trials at the Mayo Clinic in Rochester, MN. He presented the abstract on behalf of first author Ken Herrmann, MD, chair of nuclearmedicine at the University Hospital Essen in Essen, Germany.
F-18 FAPI-PET/CT is superior to F-18 FDG-PET/CT for diagnosing and staging patients with pancreatic cancer, according to a study published January 4 in the Journal of NuclearMedicine. In the future, F-18 FAPI-04 PET/CT may play a greater role in the actual clinical management of PDAC,” the group wrote.
Pluvicto (lutetium-177 [Lu-177] prostate-specific membrane antigen [PSMA]-617) appears to perform as effectively in prostate cancer patients in “real-world” settings as it did in clinical trials prior to its approval, according to clinicians at the Johns Hopkins Theranostics Center in Baltimore, MD.
The researchers leveraged what they described as an untapped opportunity that allowed them to perform SPECT just seconds after triggering seizures, with the imaging visualizing brain regions associated with language difficulties in three patients, noted lead author Sabry Barlatey, MD, PhD, of University Hospital of Bern, and colleagues. “We
In a retrospective study, a team at the University Hospital Salzburg in Austria studied baseline F-18 FDG-PET/CT imaging parameters in patients with melanoma and found they were associated with the development of metastatic brain tumors. “In A 49-year-old patient with primary clinical stage III melanoma underwent F-18 FDG-PET.
Given that relapse and mortality rates are high in these patients, the finding suggests that the technique could help clinicians choose initial treatment strategies, noted lead author Daniela Travaglio Morales, MD, of La Paz University Hospital in Madrid, and colleagues.
tesla MRI AI body composition analysis Cardiac PET Cryo/thermoablation CT colonography Genicular artery embolization Hyperpolarized xenon-129 MRI PET/MRI Photon-counting CT Radiomics Theranostics Whole-body MRI screening Image of the Year 3D PET/MR image.
Three clinical issues that may arise with theranostics treatments will require special provisions, including spot imaging, according to insights shared during the 124th annual meeting of the American Roentgen Ray Society (ARRS) in Boston. However, using lemon juice to assess toxicity will be more practical for most clinics.
Centers for Medicare & Medicaid Services (CMS) 2025 Medicare Physician Fee Schedule (MPFS) and Hospital Outpatient Prospective Payment System (HOPPS) final rules. Although the 2025 MPFS calls for an overall 2.9% payment cut for 2025 and provide an inflation-adjusted update.” for coronary CT angiography (CCTA) exams.
In a study that included 104 patients, PET/MRI provided high sensitivity and specificity for determining underlying causes, especially in patients with elevated C-reactive protein, a blood biomarker of inflammation, according to lead author Tomas Rohan, MD, of University Hospital Brno in Brno, Czechia. “To
Clinical use of imaging equipment accounts for more than 50% of greenhouse gas emissions in the radiology department, with MRI and CT equipment major contributors, researchers have reported. Clinical use of imaging equipment across all modalities made up 54% of departmental greenhouse gas emissions (2.5 kt CO 2 e) and CT for 24% (1.1
In a review of studies that included 409 patients, the technique was superior to standard-of-care FDG-PET/CT and could potentially serve as an alternative to invasive tissue sampling procedures, nuclearmedicine researchers suggested.
Blue Earth Therapeutics is highlighting early clinical results from a German trial investigating the use of a lutetium-177 (Lu-177)-labeled prostate specific antigen (PSMA) radiopharmaceutical. and its findings were published in December in the Journal of NuclearMedicine. Blue Earth said.
milla1cf Wed, 02/21/2024 - 18:58 February 21, 2024 — Blue Earth Therapeutics , a Bracco company and emerging leader in the development of innovative next generation therapeutic radiopharmaceuticals, is pleased to share the publication of promising early clinical data with 177Lu-rhPSMA-10.1 177Lu-rhPSMA-10.1 177Lu-rhPSMA-10.1
To quantify these developments, the group analyzed administered doses in 243 children and adolescents who underwent 466 clinical F-18 FDG-PET/CT or PET/MRI scans of the body at their hospital between January 2000 and May 2021. The full study is available here.
The American Roentgen Ray Society (ARRS) is awarding its two 2024 ARRS Scholarships to Ian Mark, MD, of Mayo Clinic Minnesota and Evan Calabrese, MD, PhD, of Duke University Medical Center. Mark completed his diagnostic radiology residency at Mayo Clinic, where he was chief resident. Ian Mark, MD. Image courtesy of the ARRS.
30, 2025 Earlier this month, the Society of NuclearMedicine and Molecular Imaging (SNMMI) and the Alzheimers Association released updated appropriate use criteria (AUC) for amyloid and tau PET imaging in patients with mild cognitive impairment, Alzheimers disease and other dementias. tim.hodson Thu, 01/30/2025 - 10:20 Jan.30,
“We hypothesize that the hypometabolism pattern observed in long COVID patients with brain fog using F-18 FDG-PET might primarily be a signature of astrocyte-related glutamatergic dysregulation,” wrote lead study author Eric Guedj, MD, PhD, of Marseille University Hospital.
milla1cf Thu, 06/29/2023 - 21:10 June 29, 2023 — Blue Earth Therapeutics , a Bracco company and emerging leader in the development of innovative next generation therapeutic radiopharmaceuticals, today announced highlights from early clinical and preclinical studies of 177Lu-rhPSMA-10.1 177Lu-rhPSMA-10.1 177Lu-rhPSMA-10.1 177Lu-rhPSMA-10.1
Mahmood was presented the award by the Society of NuclearMedicine and Molecular Imaging (SNMMI) at its 2023 Annual Meeting. Award recipients will have initiated, developed, and successfully implemented unique and significant transformative value within the field of nuclearmedicine and molecular imaging.
Wayne Stenzel is a senior MRI technologist at the Mayo Clinic in Rochester, Minnesota. Patrick Wojtylak is a radiologic technologist at University Hospitals Cleveland Medical Center in Cleveland, Ohio. Patrick’s efforts have led to an impressive level of quality and consistency in nuclear imaging across the enterprise.
Now, researchers have investigated the potential of using these types of AI tools in the field of clinical radiology. Support a patient-centered model in clinical radiology without straining existing resources. Ghorashi, BS, George Washington University School of Medicine, Radiology Interest Group President.
Genomics- and imaging-guided individualized subtyping is vital for Alzheimer’s disease because different subtypes may also have distinct rates and profiles of cognitive decline, potentially affecting clinical trial outcomes and treatment response,” said Dutta. “By
Published in the July issue of The Journal of NuclearMedicine , this new research demonstrates how imaging with PSMA PET/CT can potentially reduce the number of prostate biopsies and associated complications in the elderly while providing accurate staging data. Thirty-four percent of patients in the study had no pre-imaging biopsy.
Centers for Medicare and Medicaid Services (CMS), for example, did not cover amyloid PET scans outside of clinical trials for Medicare beneficiaries and only covered one scan per patient’s lifetime. Stakeholders will continue to work with the agency so that hospital outpatient facilities are adequately reimbursed in the future.
24, 2025 The Society of NuclearMedicine and Molecular Imaging (SNMMI) and the European Association of NuclearMedicine (EANM) have issued a new procedure standard/practice guideline for the use of fibroblast activation protein (FAP) PET. tim.hodson Tue, 01/28/2025 - 12:06 Jan.
christine.book Mon, 06/26/2023 - 12:46 June 26, 2023 — PET imaging with 68Ga-FAPI offers a feasible, reliable, and reproducible method for evaluating disease activity in rheumatoid arthritis, according to new research presented at the 2023 Society of NuclearMedicine and Molecular Imaging Annual Meeting. percent for 68Ga-FAPI PET/CT.
Flavio Forrer , MD, PhD, Chairman of NuclearMedicine in the Division of Radiology and NuclearMedicine at Kantonsspital St. CR and CNR demonstrated using clinical data with inserted lesions of known size, location, and contrast. Gallen in Switzerland [vii].
She will also raise awareness of nuclearmedicine’s value to clinical colleagues and patients and will be laser-focused on breaking down barriers to radiopharmaceutical availability, reimbursement, affordability, and funding. An active SNMMI member, Jacene has been involved in many aspects of the organization.
We organize all of the trending information in your field so you don't have to. Join 5,000 users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content